+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Metastatic Cancer Drug"

Metastatic Cancer Drugs Market Report 2025 - Product Thumbnail Image

Metastatic Cancer Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

The Metastatic Cancer Drug market is a subset of the Oncology Drugs market, which focuses on the treatment of cancer. Metastatic Cancer Drugs are used to treat cancer that has spread from its original site to other parts of the body. These drugs are designed to target the cancer cells and stop them from growing and spreading. They can be used alone or in combination with other treatments such as chemotherapy, radiation, and surgery. Metastatic Cancer Drugs are typically administered intravenously or orally, and can be used to treat a variety of cancers, including breast, lung, and colorectal cancer. They are often used in combination with other treatments to improve the effectiveness of the treatment. Some companies in the Metastatic Cancer Drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more